Reata Pharmaceuticals, Inc. Soared
Fri, Jul 28, 2023 at 07:41 PM
Reata Pharmaceuticals, Inc. (RETA:NASDAQ) shot up at $167.19, representing a gain of 54%. On Fri, Jul 28, 2023, RETA:NASDAQ touched a New 2-Week High of $167.19. The stock got featured on our News Catalysts scanner on Fri, Jul 28, 2023 at 05:48 PM in the 'ACQUISITION' category. From Fri, Jul 14, 2023, the stock recorded 50.00% Up Days and 54.55% Green Days
About Reata Pharmaceuticals, Inc. (RETA:NASDAQ)
Reata Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in identifying, developing, and commercializing product candidates to address rare and life-threatening diseases by targeting molecular pathways.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 118.75%
- Aurora Acquisition Corp. (AURC:NASDAQ), 113.21%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 60.19%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 54.02%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 46.36%
- Homology Medicines, Inc. (FIXX:NASDAQ), 41.49%
- ASP Isotopes Inc. (ASPI:NASDAQ), 34.44%
- Roku, Inc. (ROKU:NASDAQ), 31.41%
- View Inc. (VIEW:NASDAQ), 30.91%